These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8969322)

  • 21. Pharmacoeconomics and macular degeneration.
    Brown GC; Brown MM; Brown H; Godshalk AN
    Curr Opin Ophthalmol; 2007 May; 18(3):206-11. PubMed ID: 17435427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designed studies: their role in assuring quality and controlling costs.
    Spoeri RK
    J Healthc Resour Manag; 1996; 14(6):34-5. PubMed ID: 10159340
    [No Abstract]   [Full Text] [Related]  

  • 23. [Agreement between guidelines for pharmaco-economic research and never-before-published health-economics evaluations].
    Postma MJ; Kwik JJ; Rutten WJ; de Jong-van den Berg LT; Brouwers JR
    Ned Tijdschr Geneeskd; 2002 Jun; 146(23):1082-7. PubMed ID: 12085558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graphical methods for detecting bias in meta-analysis.
    Ferrer RL
    Fam Med; 1998 Sep; 30(8):579-83. PubMed ID: 9773289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining if disease management saves money: an introduction to meta-analysis.
    Linden A; Adams JL
    J Eval Clin Pract; 2007 Jun; 13(3):400-7. PubMed ID: 17518806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy in pharmacoeconomic literature review: lessons learned from the Navajo Code Talkers.
    Fairman KA
    J Manag Care Pharm; 2008; 14(9):886-91. PubMed ID: 19006446
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacoeconomics. A new concept of an old practice].
    Palma-Aguirre JA
    Gac Med Mex; 1998; 134(5):621-4. PubMed ID: 9842147
    [No Abstract]   [Full Text] [Related]  

  • 28. [Qualitative methods: systematic reviews in qualitative health-care research as a basis for evidence-based practice].
    Hasseler M
    Gesundheitswesen; 2007 May; 69(5):297-302. PubMed ID: 17582547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacoeconomics. I].
    Kolár J
    Ceska Slov Farm; 1997 Feb; 46(1):9-13. PubMed ID: 9221090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving meta-analysis for policy purposes.
    Hedges LV
    NIDA Res Monogr; 1997; 170():202-15. PubMed ID: 9154259
    [No Abstract]   [Full Text] [Related]  

  • 31. A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents.
    Hakim Z; Pierson JF; Pathak DS
    Pharm Pract Manag Q; 1996 Apr; 16(1):79-97. PubMed ID: 10157744
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries.
    Eljilany I; El-Dahiyat F; Curley LE; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):403-414. PubMed ID: 29779401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tidal volumes in ARDS and meta-analysis.
    Petty TL
    Am J Respir Crit Care Med; 2003 Mar; 167(6):933; author reply 933-4. PubMed ID: 12653108
    [No Abstract]   [Full Text] [Related]  

  • 34. Meta-analysis: a method for synthesizing research.
    D'Agostino RB; Weintraub M
    Clin Pharmacol Ther; 1995 Dec; 58(6):605-16. PubMed ID: 8529325
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
    Moher D; Cook DJ; Jadad AR; Tugwell P; Moher M; Jones A; Pham B; Klassen TP
    Health Technol Assess; 1999; 3(12):i-iv, 1-98. PubMed ID: 10374081
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmaceutical industry research and cost savings in community-acquired pneumonia.
    Kessler LA; Waterer GW; Barca R; Wunderink RG
    Am J Manag Care; 2002 Sep; 8(9):798-800. PubMed ID: 12234020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Meta-analyses and systematic errors in publications].
    Bias R
    Wien Med Wochenschr; 2001; 151(1-2):39-40. PubMed ID: 11281127
    [No Abstract]   [Full Text] [Related]  

  • 38. Meta-analysis as a tool for evidence-based practice: an example using the Rice meta-analysis of smoking cessation interventions.
    Leonard EE; Wynd CA
    Appl Nurs Res; 2008 Feb; 21(1):40-4. PubMed ID: 18226762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug reactions in hospitalized patients: A critique of a meta-analysis.
    Kvasz M; Allen IE; Gordon MJ; Ro EY; Estok R; Olkin I; Ross SD
    MedGenMed; 2000 Apr; 2(2):E3. PubMed ID: 11104449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.
    Garattini L; Grilli R; Scopelliti D; Mantovani L
    Pharmacoeconomics; 1995 Jan; 7(1):1-6. PubMed ID: 10155289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.